Monoclonal Antibody for Treatment of Inhalation Anthrax

NCT00138411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Bacillus Anthracis (Anthrax)

Interventions

DRUG: Ciprofloxacin 500 mg
DRUG: ETI-204 (Anthim)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)